MME and neuroendocrine neoplasm: In a different study, MEN1 and DAXX were shown to repress the expression of the membrane metalloendopeptidase (MME) and mutations in MEN1 or DAXX result in loss of this repression leading to neuroendocrine tumor proliferation27.